Skip to main
SLGL

Sol-Gel Technologies (SLGL) Stock Forecast & Price Target

Sol-Gel Technologies (SLGL) Analyst Ratings

Based on 1 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Sol-Gel Technologies Ltd is positioned favorably in the dermatology sector with its promising product pipeline, notably SGT-610, which is anticipated to be the first preventive treatment for basal cell carcinoma (BCC) lesions in Gorlin syndrome patients, a market estimated at around 11,000 individuals in the U.S. If approved, SGT-610 could potentially reach peak annual revenues exceeding $300 million, with expectations for annual sales surpassing $270 million by 2035. Additionally, the company's recent licensing agreement with Searchlight, aimed at obtaining Canadian regulatory approval for their EPSOLAY product, further underscores its strategic advancement in commercializing innovative treatments.

Bears say

Sol-Gel Technologies faces significant challenges that contribute to a negative outlook on its stock, primarily due to the slower-than-anticipated enrollment for its clinical trials, notably pushing the guidance for SGT-610's pivotal trial to 1H25. The discontinuation of the SGT-210 program for Darier disease, coupled with disappointing results from the topical erlotinib clinical study, underscores operational setbacks that may hinder the company's growth prospects. Additionally, the company has introduced a reverse stock split, raising concerns about possible medium- to long-term dilution risks, further complicating Sol-Gel's financial stability and future market performance.

Sol-Gel Technologies (SLGL) has been analyzed by 1 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Sol-Gel Technologies and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Sol-Gel Technologies (SLGL) Forecast

Analysts have given Sol-Gel Technologies (SLGL) a Strong Buy based on their latest research and market trends.

According to 1 analysts, Sol-Gel Technologies (SLGL) has a Strong Buy consensus rating as of Jan 9, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Sol-Gel Technologies (SLGL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.